Novo Nordisk Pharmaceuticals
⚠️ Moderate Risk
FEI: 3004757453 • Crawley • UNITED KINGDOM
FEI Number
3004757453
Location
Crawley
Country
UNITED KINGDOMAddress
Brighton Rd, , Crawley, , United Kingdom
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGRINSULIN
The article appears to be composed wholly or partly of insulin manufactured in the US and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for a medical emergency
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
| 12/14/2012 | 61PDL17INSULIN (INJ) (ANTI-DIABETIC) | 2060AGRINSULIN | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Novo Nordisk Pharmaceuticals's FDA import refusal history?
Novo Nordisk Pharmaceuticals (FEI: 3004757453) has 9 FDA import refusal record(s) in our database, spanning from 12/14/2012 to 12/14/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novo Nordisk Pharmaceuticals's FEI number is 3004757453.
What types of violations has Novo Nordisk Pharmaceuticals received?
Novo Nordisk Pharmaceuticals has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Novo Nordisk Pharmaceuticals come from?
All FDA import refusal data for Novo Nordisk Pharmaceuticals is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.